ARTICLE | Clinical News
Tectin: Phase II started
August 2, 2004 7:00 AM UTC
International Wex Technologies Inc. (TSX:WXI; WXITF), Vancouver, B.C. Product: Tectin Business: Neurology Molecular target: Na channel Description: Sodium channel blocker derived from puffer fish Indi...